nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP11A1—uterine cancer	0.216	0.502	CbGaD
Clomifene—CYP19A1—uterine cancer	0.112	0.259	CbGaD
Clomifene—ESR1—uterine cancer	0.103	0.239	CbGaD
Clomifene—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0885	0.256	CbGbCtD
Clomifene—SIGMAR1—Progesterone—uterine cancer	0.0725	0.209	CbGbCtD
Clomifene—ESR1—Progesterone—uterine cancer	0.0586	0.169	CbGbCtD
Clomifene—CYP2A6—Progesterone—uterine cancer	0.0301	0.087	CbGbCtD
Clomifene—CYP1A1—Progesterone—uterine cancer	0.0257	0.0743	CbGbCtD
Clomifene—CYP1A2—Progesterone—uterine cancer	0.0115	0.0332	CbGbCtD
Clomifene—ABCB1—Progesterone—uterine cancer	0.01	0.029	CbGbCtD
Clomifene—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00909	0.0262	CbGbCtD
Clomifene—CYP2E1—Etoposide—uterine cancer	0.00889	0.0257	CbGbCtD
Clomifene—CYP11A1—corpus luteum—uterine cancer	0.00823	0.198	CbGeAlD
Clomifene—ABCB1—Dactinomycin—uterine cancer	0.00797	0.023	CbGbCtD
Clomifene—CYP3A4—Progesterone—uterine cancer	0.00602	0.0174	CbGbCtD
Clomifene—CYP19A1—corpus luteum—uterine cancer	0.00535	0.128	CbGeAlD
Clomifene—CYP1A2—Etoposide—uterine cancer	0.00514	0.0149	CbGbCtD
Clomifene—ABCB1—Etoposide—uterine cancer	0.0045	0.013	CbGbCtD
Clomifene—ABCB1—Doxorubicin—uterine cancer	0.00307	0.00886	CbGbCtD
Clomifene—CYP3A4—Etoposide—uterine cancer	0.00269	0.00778	CbGbCtD
Clomifene—CYP19A1—semen—uterine cancer	0.0025	0.0601	CbGeAlD
Clomifene—CYP3A4—Doxorubicin—uterine cancer	0.00184	0.00531	CbGbCtD
Clomifene—EBP—uterine cervix—uterine cancer	0.00167	0.04	CbGeAlD
Clomifene—ESR1—oviduct—uterine cancer	0.0016	0.0383	CbGeAlD
Clomifene—EBP—uterus—uterine cancer	0.00139	0.0334	CbGeAlD
Clomifene—EBP—female reproductive system—uterine cancer	0.00125	0.03	CbGeAlD
Clomifene—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00108	1	CbGdCrCtD
Clomifene—CYP11A1—decidua—uterine cancer	0.000671	0.0161	CbGeAlD
Clomifene—SIGMAR1—myometrium—uterine cancer	0.000578	0.0139	CbGeAlD
Clomifene—CYP11A1—female reproductive system—uterine cancer	0.000527	0.0127	CbGeAlD
Clomifene—Ospemifene—ESR1—uterine cancer	0.000517	0.331	CrCbGaD
Clomifene—ESR1—myometrium—uterine cancer	0.000511	0.0123	CbGeAlD
Clomifene—CYP11A1—female gonad—uterine cancer	0.00048	0.0115	CbGeAlD
Clomifene—KCNH2—myometrium—uterine cancer	0.00046	0.011	CbGeAlD
Clomifene—SIGMAR1—uterine cervix—uterine cancer	0.00045	0.0108	CbGeAlD
Clomifene—SIGMAR1—smooth muscle tissue—uterine cancer	0.000437	0.0105	CbGeAlD
Clomifene—SIGMAR1—decidua—uterine cancer	0.000428	0.0103	CbGeAlD
Clomifene—Toremifene—ESR1—uterine cancer	0.000421	0.27	CrCbGaD
Clomifene—CYP19A1—endometrium—uterine cancer	0.000414	0.00993	CbGeAlD
Clomifene—SIGMAR1—endometrium—uterine cancer	0.000407	0.00977	CbGeAlD
Clomifene—ESR1—epithelium—uterine cancer	0.000401	0.00963	CbGeAlD
Clomifene—ESR1—uterine cervix—uterine cancer	0.000398	0.00954	CbGeAlD
Clomifene—CYP2A6—vagina—uterine cancer	0.000395	0.00949	CbGeAlD
Clomifene—SIGMAR1—mammalian vulva—uterine cancer	0.000393	0.00945	CbGeAlD
Clomifene—ESR1—smooth muscle tissue—uterine cancer	0.000386	0.00928	CbGeAlD
Clomifene—CYP19A1—uterus—uterine cancer	0.000381	0.00915	CbGeAlD
Clomifene—ESR1—decidua—uterine cancer	0.000379	0.00909	CbGeAlD
Clomifene—SIGMAR1—uterus—uterine cancer	0.000375	0.009	CbGeAlD
Clomifene—ESR1—renal system—uterine cancer	0.000372	0.00893	CbGeAlD
Clomifene—ESR1—endometrium—uterine cancer	0.00036	0.00863	CbGeAlD
Clomifene—KCNH2—uterine cervix—uterine cancer	0.000358	0.00859	CbGeAlD
Clomifene—CYP19A1—female reproductive system—uterine cancer	0.000343	0.00823	CbGeAlD
Clomifene—KCNH2—renal system—uterine cancer	0.000335	0.00804	CbGeAlD
Clomifene—ESR1—uterus—uterine cancer	0.000331	0.00795	CbGeAlD
Clomifene—KCNH2—endometrium—uterine cancer	0.000324	0.00777	CbGeAlD
Clomifene—CYP19A1—female gonad—uterine cancer	0.000312	0.00749	CbGeAlD
Clomifene—CYP11A1—lymph node—uterine cancer	0.000309	0.00741	CbGeAlD
Clomifene—SIGMAR1—female gonad—uterine cancer	0.000307	0.00736	CbGeAlD
Clomifene—CYP1A1—epithelium—uterine cancer	0.000305	0.00732	CbGeAlD
Clomifene—SIGMAR1—vagina—uterine cancer	0.000305	0.00732	CbGeAlD
Clomifene—CYP1A1—uterine cervix—uterine cancer	0.000302	0.00726	CbGeAlD
Clomifene—KCNH2—uterus—uterine cancer	0.000298	0.00716	CbGeAlD
Clomifene—ESR1—female reproductive system—uterine cancer	0.000298	0.00715	CbGeAlD
Clomifene—CYP1A2—renal system—uterine cancer	0.000287	0.00688	CbGeAlD
Clomifene—CYP1A1—renal system—uterine cancer	0.000283	0.00679	CbGeAlD
Clomifene—Tamoxifen—ESR2—uterine cancer	0.000273	0.175	CrCbGaD
Clomifene—ESR1—female gonad—uterine cancer	0.000271	0.00651	CbGeAlD
Clomifene—ESR1—vagina—uterine cancer	0.000269	0.00647	CbGeAlD
Clomifene—KCNH2—female reproductive system—uterine cancer	0.000268	0.00644	CbGeAlD
Clomifene—CYP1A1—mammalian vulva—uterine cancer	0.000264	0.00635	CbGeAlD
Clomifene—CYP2E1—renal system—uterine cancer	0.000258	0.00619	CbGeAlD
Clomifene—CYP1A1—uterus—uterine cancer	0.000252	0.00605	CbGeAlD
Clomifene—KCNH2—female gonad—uterine cancer	0.000244	0.00586	CbGeAlD
Clomifene—KCNH2—vagina—uterine cancer	0.000243	0.00582	CbGeAlD
Clomifene—CYP1A1—female reproductive system—uterine cancer	0.000226	0.00544	CbGeAlD
Clomifene—CYP3A4—renal system—uterine cancer	0.000208	0.00498	CbGeAlD
Clomifene—CYP2E1—female reproductive system—uterine cancer	0.000207	0.00496	CbGeAlD
Clomifene—CYP1A1—female gonad—uterine cancer	0.000206	0.00495	CbGeAlD
Clomifene—CYP1A1—vagina—uterine cancer	0.000205	0.00492	CbGeAlD
Clomifene—ABCB1—myometrium—uterine cancer	0.000202	0.00484	CbGeAlD
Clomifene—CYP19A1—lymph node—uterine cancer	0.0002	0.00481	CbGeAlD
Clomifene—SIGMAR1—lymph node—uterine cancer	0.000197	0.00473	CbGeAlD
Clomifene—Tamoxifen—CYP19A1—uterine cancer	0.000183	0.117	CrCbGaD
Clomifene—ESR1—lymph node—uterine cancer	0.000174	0.00418	CbGeAlD
Clomifene—Tamoxifen—ESR1—uterine cancer	0.000168	0.108	CrCbGaD
Clomifene—CYP3A4—female reproductive system—uterine cancer	0.000166	0.00399	CbGeAlD
Clomifene—ABCB1—epithelium—uterine cancer	0.000158	0.0038	CbGeAlD
Clomifene—ABCB1—uterine cervix—uterine cancer	0.000157	0.00377	CbGeAlD
Clomifene—KCNH2—lymph node—uterine cancer	0.000157	0.00377	CbGeAlD
Clomifene—ABCB1—decidua—uterine cancer	0.00015	0.00359	CbGeAlD
Clomifene—ABCB1—renal system—uterine cancer	0.000147	0.00353	CbGeAlD
Clomifene—ABCB1—endometrium—uterine cancer	0.000142	0.00341	CbGeAlD
Clomifene—ABCB1—mammalian vulva—uterine cancer	0.000137	0.0033	CbGeAlD
Clomifene—CYP1A1—lymph node—uterine cancer	0.000132	0.00318	CbGeAlD
Clomifene—ABCB1—uterus—uterine cancer	0.000131	0.00314	CbGeAlD
Clomifene—ABCB1—female reproductive system—uterine cancer	0.000118	0.00282	CbGeAlD
Clomifene—ABCB1—female gonad—uterine cancer	0.000107	0.00257	CbGeAlD
Clomifene—ABCB1—vagina—uterine cancer	0.000106	0.00255	CbGeAlD
Clomifene—Erythema—Medroxyprogesterone Acetate—uterine cancer	9.86e-05	0.0007	CcSEcCtD
Clomifene—Vertigo—Progesterone—uterine cancer	9.77e-05	0.000694	CcSEcCtD
Clomifene—Syncope—Progesterone—uterine cancer	9.76e-05	0.000693	CcSEcCtD
Clomifene—Flatulence—Medroxyprogesterone Acetate—uterine cancer	9.71e-05	0.00069	CcSEcCtD
Clomifene—Tension—Medroxyprogesterone Acetate—uterine cancer	9.67e-05	0.000687	CcSEcCtD
Clomifene—Dermatitis atopic—Epirubicin—uterine cancer	9.64e-05	0.000685	CcSEcCtD
Clomifene—Palpitations—Progesterone—uterine cancer	9.61e-05	0.000683	CcSEcCtD
Clomifene—Nervousness—Medroxyprogesterone Acetate—uterine cancer	9.57e-05	0.00068	CcSEcCtD
Clomifene—Loss of consciousness—Progesterone—uterine cancer	9.56e-05	0.000679	CcSEcCtD
Clomifene—Back pain—Medroxyprogesterone Acetate—uterine cancer	9.54e-05	0.000677	CcSEcCtD
Clomifene—Convulsion—Progesterone—uterine cancer	9.43e-05	0.000669	CcSEcCtD
Clomifene—Scotoma—Epirubicin—uterine cancer	9.4e-05	0.000667	CcSEcCtD
Clomifene—Hypertension—Progesterone—uterine cancer	9.39e-05	0.000667	CcSEcCtD
Clomifene—Thrombosis—Doxorubicin—uterine cancer	9.33e-05	0.000663	CcSEcCtD
Clomifene—Myalgia—Progesterone—uterine cancer	9.26e-05	0.000658	CcSEcCtD
Clomifene—Arthralgia—Progesterone—uterine cancer	9.26e-05	0.000658	CcSEcCtD
Clomifene—Chest pain—Progesterone—uterine cancer	9.26e-05	0.000658	CcSEcCtD
Clomifene—Anxiety—Progesterone—uterine cancer	9.23e-05	0.000656	CcSEcCtD
Clomifene—Dermatitis atopic—Doxorubicin—uterine cancer	8.92e-05	0.000634	CcSEcCtD
Clomifene—Oedema—Progesterone—uterine cancer	8.88e-05	0.000631	CcSEcCtD
Clomifene—Vertigo—Medroxyprogesterone Acetate—uterine cancer	8.86e-05	0.000629	CcSEcCtD
Clomifene—Syncope—Medroxyprogesterone Acetate—uterine cancer	8.84e-05	0.000628	CcSEcCtD
Clomifene—Hepatitis—Dactinomycin—uterine cancer	8.83e-05	0.000627	CcSEcCtD
Clomifene—Shock—Progesterone—uterine cancer	8.73e-05	0.00062	CcSEcCtD
Clomifene—Palpitations—Medroxyprogesterone Acetate—uterine cancer	8.71e-05	0.000619	CcSEcCtD
Clomifene—Scotoma—Doxorubicin—uterine cancer	8.69e-05	0.000618	CcSEcCtD
Clomifene—Tachycardia—Progesterone—uterine cancer	8.66e-05	0.000615	CcSEcCtD
Clomifene—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	8.66e-05	0.000615	CcSEcCtD
Clomifene—Convulsion—Medroxyprogesterone Acetate—uterine cancer	8.54e-05	0.000607	CcSEcCtD
Clomifene—Myalgia—Medroxyprogesterone Acetate—uterine cancer	8.39e-05	0.000596	CcSEcCtD
Clomifene—Chest pain—Medroxyprogesterone Acetate—uterine cancer	8.39e-05	0.000596	CcSEcCtD
Clomifene—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	8.39e-05	0.000596	CcSEcCtD
Clomifene—Anxiety—Medroxyprogesterone Acetate—uterine cancer	8.36e-05	0.000594	CcSEcCtD
Clomifene—Erythema multiforme—Dactinomycin—uterine cancer	8.35e-05	0.000593	CcSEcCtD
Clomifene—Flushing—Dactinomycin—uterine cancer	8.2e-05	0.000582	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Progesterone—uterine cancer	8.09e-05	0.000575	CcSEcCtD
Clomifene—Oedema—Medroxyprogesterone Acetate—uterine cancer	8.05e-05	0.000571	CcSEcCtD
Clomifene—Insomnia—Progesterone—uterine cancer	8.03e-05	0.00057	CcSEcCtD
Clomifene—Paraesthesia—Progesterone—uterine cancer	7.97e-05	0.000566	CcSEcCtD
Clomifene—Dyspnoea—Progesterone—uterine cancer	7.92e-05	0.000562	CcSEcCtD
Clomifene—Shock—Medroxyprogesterone Acetate—uterine cancer	7.92e-05	0.000562	CcSEcCtD
Clomifene—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	7.85e-05	0.000558	CcSEcCtD
Clomifene—Alopecia—Dactinomycin—uterine cancer	7.81e-05	0.000554	CcSEcCtD
Clomifene—Erythema—Dactinomycin—uterine cancer	7.69e-05	0.000546	CcSEcCtD
Clomifene—Fatigue—Progesterone—uterine cancer	7.65e-05	0.000544	CcSEcCtD
Clomifene—Pain—Progesterone—uterine cancer	7.59e-05	0.000539	CcSEcCtD
Clomifene—Constipation—Progesterone—uterine cancer	7.59e-05	0.000539	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	7.33e-05	0.000521	CcSEcCtD
Clomifene—Insomnia—Medroxyprogesterone Acetate—uterine cancer	7.28e-05	0.000517	CcSEcCtD
Clomifene—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	7.22e-05	0.000513	CcSEcCtD
Clomifene—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	7.17e-05	0.000509	CcSEcCtD
Clomifene—Pulmonary embolism—Epirubicin—uterine cancer	7.14e-05	0.000507	CcSEcCtD
Clomifene—Hepatocellular injury—Epirubicin—uterine cancer	7.14e-05	0.000507	CcSEcCtD
Clomifene—Urticaria—Progesterone—uterine cancer	7.05e-05	0.000501	CcSEcCtD
Clomifene—Body temperature increased—Progesterone—uterine cancer	7.02e-05	0.000499	CcSEcCtD
Clomifene—Renal failure—Etoposide—uterine cancer	7e-05	0.000497	CcSEcCtD
Clomifene—Jaundice—Etoposide—uterine cancer	6.94e-05	0.000493	CcSEcCtD
Clomifene—Fatigue—Medroxyprogesterone Acetate—uterine cancer	6.94e-05	0.000493	CcSEcCtD
Clomifene—ABCB1—lymph node—uterine cancer	6.88e-05	0.00165	CbGeAlD
Clomifene—Constipation—Medroxyprogesterone Acetate—uterine cancer	6.88e-05	0.000489	CcSEcCtD
Clomifene—Pulmonary embolism—Doxorubicin—uterine cancer	6.6e-05	0.000469	CcSEcCtD
Clomifene—Hepatocellular injury—Doxorubicin—uterine cancer	6.6e-05	0.000469	CcSEcCtD
Clomifene—Myalgia—Dactinomycin—uterine cancer	6.55e-05	0.000465	CcSEcCtD
Clomifene—Hypersensitivity—Progesterone—uterine cancer	6.54e-05	0.000465	CcSEcCtD
Clomifene—Neoplasm—Epirubicin—uterine cancer	6.45e-05	0.000458	CcSEcCtD
Clomifene—Urticaria—Medroxyprogesterone Acetate—uterine cancer	6.39e-05	0.000454	CcSEcCtD
Clomifene—Asthenia—Progesterone—uterine cancer	6.37e-05	0.000452	CcSEcCtD
Clomifene—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	6.36e-05	0.000452	CcSEcCtD
Clomifene—Pruritus—Progesterone—uterine cancer	6.28e-05	0.000446	CcSEcCtD
Clomifene—Oedema—Dactinomycin—uterine cancer	6.28e-05	0.000446	CcSEcCtD
Clomifene—Mental disability—Epirubicin—uterine cancer	6.19e-05	0.00044	CcSEcCtD
Clomifene—Diarrhoea—Progesterone—uterine cancer	6.07e-05	0.000431	CcSEcCtD
Clomifene—Erythema multiforme—Etoposide—uterine cancer	6.04e-05	0.000429	CcSEcCtD
Clomifene—Phlebitis—Epirubicin—uterine cancer	6.01e-05	0.000427	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—uterine cancer	5.98e-05	0.000425	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—uterine cancer	5.97e-05	0.000424	CcSEcCtD
Clomifene—Flushing—Etoposide—uterine cancer	5.93e-05	0.000421	CcSEcCtD
Clomifene—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.93e-05	0.000421	CcSEcCtD
Clomifene—Dizziness—Progesterone—uterine cancer	5.87e-05	0.000417	CcSEcCtD
Clomifene—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.77e-05	0.00041	CcSEcCtD
Clomifene—Eye pain—Epirubicin—uterine cancer	5.74e-05	0.000408	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—uterine cancer	5.73e-05	0.000407	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dactinomycin—uterine cancer	5.72e-05	0.000406	CcSEcCtD
Clomifene—Pruritus—Medroxyprogesterone Acetate—uterine cancer	5.69e-05	0.000404	CcSEcCtD
Clomifene—Alopecia—Etoposide—uterine cancer	5.65e-05	0.000401	CcSEcCtD
Clomifene—Vomiting—Progesterone—uterine cancer	5.64e-05	0.000401	CcSEcCtD
Clomifene—Rash—Progesterone—uterine cancer	5.6e-05	0.000398	CcSEcCtD
Clomifene—Dermatitis—Progesterone—uterine cancer	5.59e-05	0.000397	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—uterine cancer	5.56e-05	0.000395	CcSEcCtD
Clomifene—Headache—Progesterone—uterine cancer	5.56e-05	0.000395	CcSEcCtD
Clomifene—Hot flush—Epirubicin—uterine cancer	5.54e-05	0.000393	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—uterine cancer	5.54e-05	0.000393	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—uterine cancer	5.51e-05	0.000392	CcSEcCtD
Clomifene—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	5.5e-05	0.000391	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—uterine cancer	5.49e-05	0.00039	CcSEcCtD
Clomifene—Fatigue—Dactinomycin—uterine cancer	5.41e-05	0.000384	CcSEcCtD
Clomifene—Back pain—Etoposide—uterine cancer	5.38e-05	0.000382	CcSEcCtD
Clomifene—Pain—Dactinomycin—uterine cancer	5.37e-05	0.000381	CcSEcCtD
Clomifene—Dizziness—Medroxyprogesterone Acetate—uterine cancer	5.32e-05	0.000378	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—uterine cancer	5.31e-05	0.000377	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—uterine cancer	5.29e-05	0.000375	CcSEcCtD
Clomifene—Nausea—Progesterone—uterine cancer	5.27e-05	0.000375	CcSEcCtD
Clomifene—Diplopia—Epirubicin—uterine cancer	5.18e-05	0.000368	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—uterine cancer	5.12e-05	0.000364	CcSEcCtD
Clomifene—Vomiting—Medroxyprogesterone Acetate—uterine cancer	5.12e-05	0.000363	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—uterine cancer	5.1e-05	0.000362	CcSEcCtD
Clomifene—Affect lability—Epirubicin—uterine cancer	5.1e-05	0.000362	CcSEcCtD
Clomifene—Migraine—Epirubicin—uterine cancer	5.1e-05	0.000362	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—uterine cancer	5.08e-05	0.000361	CcSEcCtD
Clomifene—Rash—Medroxyprogesterone Acetate—uterine cancer	5.07e-05	0.00036	CcSEcCtD
Clomifene—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	5.07e-05	0.00036	CcSEcCtD
Clomifene—Headache—Medroxyprogesterone Acetate—uterine cancer	5.04e-05	0.000358	CcSEcCtD
Clomifene—Vertigo—Etoposide—uterine cancer	5e-05	0.000355	CcSEcCtD
Clomifene—Body temperature increased—Dactinomycin—uterine cancer	4.96e-05	0.000352	CcSEcCtD
Clomifene—Mood swings—Epirubicin—uterine cancer	4.91e-05	0.000349	CcSEcCtD
Clomifene—Loss of consciousness—Etoposide—uterine cancer	4.89e-05	0.000347	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—uterine cancer	4.89e-05	0.000347	CcSEcCtD
Clomifene—Convulsion—Etoposide—uterine cancer	4.82e-05	0.000342	CcSEcCtD
Clomifene—Hypertension—Etoposide—uterine cancer	4.8e-05	0.000341	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—uterine cancer	4.79e-05	0.00034	CcSEcCtD
Clomifene—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.78e-05	0.000339	CcSEcCtD
Clomifene—Chest pain—Etoposide—uterine cancer	4.74e-05	0.000337	CcSEcCtD
Clomifene—Migraine—Doxorubicin—uterine cancer	4.72e-05	0.000335	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—uterine cancer	4.72e-05	0.000335	CcSEcCtD
Clomifene—Hypersensitivity—Dactinomycin—uterine cancer	4.62e-05	0.000328	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—uterine cancer	4.54e-05	0.000322	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—uterine cancer	4.51e-05	0.00032	CcSEcCtD
Clomifene—Asthenia—Dactinomycin—uterine cancer	4.5e-05	0.00032	CcSEcCtD
Clomifene—Tachycardia—Etoposide—uterine cancer	4.43e-05	0.000315	CcSEcCtD
Clomifene—Pancreatitis—Epirubicin—uterine cancer	4.39e-05	0.000312	CcSEcCtD
Clomifene—Diarrhoea—Dactinomycin—uterine cancer	4.29e-05	0.000305	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—uterine cancer	4.17e-05	0.000296	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—uterine cancer	4.14e-05	0.000294	CcSEcCtD
Clomifene—Paraesthesia—Etoposide—uterine cancer	4.08e-05	0.00029	CcSEcCtD
Clomifene—Weight increased—Epirubicin—uterine cancer	4.07e-05	0.000289	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—uterine cancer	4.06e-05	0.000288	CcSEcCtD
Clomifene—Dyspnoea—Etoposide—uterine cancer	4.05e-05	0.000288	CcSEcCtD
Clomifene—Vomiting—Dactinomycin—uterine cancer	3.99e-05	0.000283	CcSEcCtD
Clomifene—Rash—Dactinomycin—uterine cancer	3.96e-05	0.000281	CcSEcCtD
Clomifene—Renal failure—Epirubicin—uterine cancer	3.92e-05	0.000279	CcSEcCtD
Clomifene—Fatigue—Etoposide—uterine cancer	3.92e-05	0.000278	CcSEcCtD
Clomifene—Jaundice—Epirubicin—uterine cancer	3.89e-05	0.000276	CcSEcCtD
Clomifene—Pain—Etoposide—uterine cancer	3.88e-05	0.000276	CcSEcCtD
Clomifene—Constipation—Etoposide—uterine cancer	3.88e-05	0.000276	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—uterine cancer	3.83e-05	0.000272	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—uterine cancer	3.77e-05	0.000268	CcSEcCtD
Clomifene—Nausea—Dactinomycin—uterine cancer	3.73e-05	0.000265	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—uterine cancer	3.63e-05	0.000258	CcSEcCtD
Clomifene—Urticaria—Etoposide—uterine cancer	3.61e-05	0.000256	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—uterine cancer	3.6e-05	0.000256	CcSEcCtD
Clomifene—Body temperature increased—Etoposide—uterine cancer	3.59e-05	0.000255	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—uterine cancer	3.58e-05	0.000255	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—uterine cancer	3.45e-05	0.000245	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—uterine cancer	3.39e-05	0.000241	CcSEcCtD
Clomifene—Hypersensitivity—Etoposide—uterine cancer	3.35e-05	0.000238	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—uterine cancer	3.34e-05	0.000237	CcSEcCtD
Clomifene—Flushing—Epirubicin—uterine cancer	3.33e-05	0.000236	CcSEcCtD
Clomifene—Hepatitis—Doxorubicin—uterine cancer	3.32e-05	0.000236	CcSEcCtD
Clomifene—Asthenia—Etoposide—uterine cancer	3.26e-05	0.000231	CcSEcCtD
Clomifene—Pruritus—Etoposide—uterine cancer	3.21e-05	0.000228	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—uterine cancer	3.2e-05	0.000227	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—uterine cancer	3.2e-05	0.000227	CcSEcCtD
Clomifene—Alopecia—Epirubicin—uterine cancer	3.17e-05	0.000225	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—uterine cancer	3.13e-05	0.000223	CcSEcCtD
Clomifene—Erythema—Epirubicin—uterine cancer	3.12e-05	0.000222	CcSEcCtD
Clomifene—Diarrhoea—Etoposide—uterine cancer	3.11e-05	0.000221	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—uterine cancer	3.09e-05	0.00022	CcSEcCtD
Clomifene—Flushing—Doxorubicin—uterine cancer	3.08e-05	0.000219	CcSEcCtD
Clomifene—Flatulence—Epirubicin—uterine cancer	3.07e-05	0.000218	CcSEcCtD
Clomifene—Tension—Epirubicin—uterine cancer	3.06e-05	0.000217	CcSEcCtD
Clomifene—Nervousness—Epirubicin—uterine cancer	3.03e-05	0.000215	CcSEcCtD
Clomifene—Back pain—Epirubicin—uterine cancer	3.02e-05	0.000214	CcSEcCtD
Clomifene—Dizziness—Etoposide—uterine cancer	3e-05	0.000213	CcSEcCtD
Clomifene—Arrhythmia—Doxorubicin—uterine cancer	2.96e-05	0.00021	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—uterine cancer	2.94e-05	0.000209	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—uterine cancer	2.93e-05	0.000208	CcSEcCtD
Clomifene—Vomiting—Etoposide—uterine cancer	2.89e-05	0.000205	CcSEcCtD
Clomifene—Erythema—Doxorubicin—uterine cancer	2.89e-05	0.000205	CcSEcCtD
Clomifene—Rash—Etoposide—uterine cancer	2.86e-05	0.000203	CcSEcCtD
Clomifene—Dermatitis—Etoposide—uterine cancer	2.86e-05	0.000203	CcSEcCtD
Clomifene—Headache—Etoposide—uterine cancer	2.85e-05	0.000202	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—uterine cancer	2.84e-05	0.000202	CcSEcCtD
Clomifene—Tension—Doxorubicin—uterine cancer	2.83e-05	0.000201	CcSEcCtD
Clomifene—Nervousness—Doxorubicin—uterine cancer	2.8e-05	0.000199	CcSEcCtD
Clomifene—Vertigo—Epirubicin—uterine cancer	2.8e-05	0.000199	CcSEcCtD
Clomifene—Syncope—Epirubicin—uterine cancer	2.8e-05	0.000199	CcSEcCtD
Clomifene—Back pain—Doxorubicin—uterine cancer	2.79e-05	0.000198	CcSEcCtD
Clomifene—Palpitations—Epirubicin—uterine cancer	2.76e-05	0.000196	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—uterine cancer	2.74e-05	0.000195	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—uterine cancer	2.72e-05	0.000193	CcSEcCtD
Clomifene—Convulsion—Epirubicin—uterine cancer	2.7e-05	0.000192	CcSEcCtD
Clomifene—Nausea—Etoposide—uterine cancer	2.7e-05	0.000192	CcSEcCtD
Clomifene—Hypertension—Epirubicin—uterine cancer	2.69e-05	0.000191	CcSEcCtD
Clomifene—Myalgia—Epirubicin—uterine cancer	2.66e-05	0.000189	CcSEcCtD
Clomifene—Chest pain—Epirubicin—uterine cancer	2.66e-05	0.000189	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—uterine cancer	2.66e-05	0.000189	CcSEcCtD
Clomifene—Anxiety—Epirubicin—uterine cancer	2.65e-05	0.000188	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—uterine cancer	2.59e-05	0.000184	CcSEcCtD
Clomifene—Syncope—Doxorubicin—uterine cancer	2.59e-05	0.000184	CcSEcCtD
Clomifene—Palpitations—Doxorubicin—uterine cancer	2.55e-05	0.000181	CcSEcCtD
Clomifene—Oedema—Epirubicin—uterine cancer	2.55e-05	0.000181	CcSEcCtD
Clomifene—Loss of consciousness—Doxorubicin—uterine cancer	2.54e-05	0.00018	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.52e-05	0.000661	CbGpPWpGaD
Clomifene—Shock—Epirubicin—uterine cancer	2.5e-05	0.000178	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—uterine cancer	2.5e-05	0.000178	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.5e-05	0.000654	CbGpPWpGaD
Clomifene—Hypertension—Doxorubicin—uterine cancer	2.49e-05	0.000177	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—uterine cancer	2.48e-05	0.000176	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.48e-05	0.00065	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—AKT1—uterine cancer	2.48e-05	0.00065	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.46e-05	0.000645	CbGpPWpGaD
Clomifene—Chest pain—Doxorubicin—uterine cancer	2.46e-05	0.000175	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—uterine cancer	2.46e-05	0.000175	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—uterine cancer	2.46e-05	0.000175	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—uterine cancer	2.45e-05	0.000174	CcSEcCtD
Clomifene—ESR1—Signaling by ERBB4—PTEN—uterine cancer	2.45e-05	0.000641	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.43e-05	0.000637	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.43e-05	0.000636	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.41e-05	0.000631	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.4e-05	0.000629	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.39e-05	0.000626	CbGpPWpGaD
Clomifene—Oedema—Doxorubicin—uterine cancer	2.36e-05	0.000167	CcSEcCtD
Clomifene—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.35e-05	0.000616	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.35e-05	0.000615	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.34e-05	0.000613	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.33e-05	0.000611	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.33e-05	0.00061	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.32e-05	0.000165	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.32e-05	0.000607	CbGpPWpGaD
Clomifene—Shock—Doxorubicin—uterine cancer	2.32e-05	0.000165	CcSEcCtD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.31e-05	0.000606	CbGpPWpGaD
Clomifene—Insomnia—Epirubicin—uterine cancer	2.3e-05	0.000164	CcSEcCtD
Clomifene—CYP19A1—Metabolism—STAR—uterine cancer	2.3e-05	0.000603	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKR1B1—uterine cancer	2.3e-05	0.000603	CbGpPWpGaD
Clomifene—Tachycardia—Doxorubicin—uterine cancer	2.3e-05	0.000163	CcSEcCtD
Clomifene—Paraesthesia—Epirubicin—uterine cancer	2.29e-05	0.000162	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.28e-05	0.000597	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—RRM2—uterine cancer	2.27e-05	0.000595	CbGpPWpGaD
Clomifene—Dyspnoea—Epirubicin—uterine cancer	2.27e-05	0.000161	CcSEcCtD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.25e-05	0.000589	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.24e-05	0.000587	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.22e-05	0.000582	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.21e-05	0.00058	CbGpPWpGaD
Clomifene—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.21e-05	0.000579	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—DCN—uterine cancer	2.21e-05	0.000578	CbGpPWpGaD
Clomifene—Fatigue—Epirubicin—uterine cancer	2.19e-05	0.000156	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.19e-05	0.000573	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—NRAS—uterine cancer	2.18e-05	0.000572	CbGpPWpGaD
Clomifene—Constipation—Epirubicin—uterine cancer	2.18e-05	0.000155	CcSEcCtD
Clomifene—Pain—Epirubicin—uterine cancer	2.18e-05	0.000155	CcSEcCtD
Clomifene—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.17e-05	0.000569	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.15e-05	0.000152	CcSEcCtD
Clomifene—Insomnia—Doxorubicin—uterine cancer	2.13e-05	0.000151	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—uterine cancer	2.12e-05	0.00015	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.11e-05	0.000553	CbGpPWpGaD
Clomifene—Dyspnoea—Doxorubicin—uterine cancer	2.1e-05	0.000149	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.09e-05	0.000548	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.07e-05	0.000541	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.04e-05	0.000534	CbGpPWpGaD
Clomifene—Fatigue—Doxorubicin—uterine cancer	2.03e-05	0.000144	CcSEcCtD
Clomifene—Urticaria—Epirubicin—uterine cancer	2.02e-05	0.000144	CcSEcCtD
Clomifene—Constipation—Doxorubicin—uterine cancer	2.01e-05	0.000143	CcSEcCtD
Clomifene—Pain—Doxorubicin—uterine cancer	2.01e-05	0.000143	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—uterine cancer	2.01e-05	0.000143	CcSEcCtD
Clomifene—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	2e-05	0.000525	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SRD5A2—uterine cancer	2e-05	0.000525	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—NDUFB11—uterine cancer	2e-05	0.000525	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	1.98e-05	0.000519	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.97e-05	0.000517	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKR1C3—uterine cancer	1.96e-05	0.000514	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	1.96e-05	0.000513	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.95e-05	0.000512	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.95e-05	0.000512	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.94e-05	0.000509	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.89e-05	0.000495	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SRD5A2—uterine cancer	1.89e-05	0.000495	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NDUFB11—uterine cancer	1.89e-05	0.000495	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—KRAS—uterine cancer	1.88e-05	0.000492	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.88e-05	0.000491	CbGpPWpGaD
Clomifene—Hypersensitivity—Epirubicin—uterine cancer	1.88e-05	0.000133	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—uterine cancer	1.87e-05	0.000133	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—uterine cancer	1.86e-05	0.000132	CcSEcCtD
Clomifene—ESR1—Signaling Pathways—AKR1B10—uterine cancer	1.85e-05	0.000485	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.84e-05	0.000482	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.83e-05	0.00048	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—STAR—uterine cancer	1.83e-05	0.00048	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKR1B1—uterine cancer	1.83e-05	0.00048	CbGpPWpGaD
Clomifene—Asthenia—Epirubicin—uterine cancer	1.83e-05	0.00013	CcSEcCtD
Clomifene—CYP19A1—Metabolism—POLD1—uterine cancer	1.81e-05	0.000473	CbGpPWpGaD
Clomifene—Pruritus—Epirubicin—uterine cancer	1.8e-05	0.000128	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.76e-05	0.00046	CbGpPWpGaD
Clomifene—Diarrhoea—Epirubicin—uterine cancer	1.74e-05	0.000124	CcSEcCtD
Clomifene—Hypersensitivity—Doxorubicin—uterine cancer	1.74e-05	0.000123	CcSEcCtD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.73e-05	0.000454	CbGpPWpGaD
Clomifene—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.73e-05	0.000453	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.73e-05	0.000452	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.72e-05	0.000452	CbGpPWpGaD
Clomifene—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.71e-05	0.000447	CbGpPWpGaD
Clomifene—Asthenia—Doxorubicin—uterine cancer	1.69e-05	0.00012	CcSEcCtD
Clomifene—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000443	CbGpPWpGaD
Clomifene—Dizziness—Epirubicin—uterine cancer	1.68e-05	0.00012	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.68e-05	0.00044	CbGpPWpGaD
Clomifene—Pruritus—Doxorubicin—uterine cancer	1.67e-05	0.000118	CcSEcCtD
Clomifene—Vomiting—Epirubicin—uterine cancer	1.62e-05	0.000115	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—uterine cancer	1.61e-05	0.000114	CcSEcCtD
Clomifene—Rash—Epirubicin—uterine cancer	1.61e-05	0.000114	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—uterine cancer	1.6e-05	0.000114	CcSEcCtD
Clomifene—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.6e-05	0.000419	CbGpPWpGaD
Clomifene—Headache—Epirubicin—uterine cancer	1.59e-05	0.000113	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.58e-05	0.000415	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.57e-05	0.00041	CbGpPWpGaD
Clomifene—Dizziness—Doxorubicin—uterine cancer	1.56e-05	0.000111	CcSEcCtD
Clomifene—ESR1—Signaling Pathways—RNF43—uterine cancer	1.54e-05	0.000402	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CYP19A1—uterine cancer	1.53e-05	0.000401	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—STK11—uterine cancer	1.53e-05	0.000401	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—HRAS—uterine cancer	1.53e-05	0.0004	CbGpPWpGaD
Clomifene—Nausea—Epirubicin—uterine cancer	1.51e-05	0.000107	CcSEcCtD
Clomifene—ABCB1—Metabolism—NDUFB11—uterine cancer	1.51e-05	0.000395	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SRD5A2—uterine cancer	1.51e-05	0.000395	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—RRM2—uterine cancer	1.51e-05	0.000394	CbGpPWpGaD
Clomifene—Vomiting—Doxorubicin—uterine cancer	1.5e-05	0.000106	CcSEcCtD
Clomifene—Rash—Doxorubicin—uterine cancer	1.49e-05	0.000105	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—uterine cancer	1.48e-05	0.000105	CcSEcCtD
Clomifene—EBP—Metabolism—PTEN—uterine cancer	1.48e-05	0.000387	CbGpPWpGaD
Clomifene—Headache—Doxorubicin—uterine cancer	1.48e-05	0.000105	CcSEcCtD
Clomifene—CYP19A1—Metabolism—DCN—uterine cancer	1.46e-05	0.000383	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PGR—uterine cancer	1.46e-05	0.000382	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.45e-05	0.000381	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—STAR—uterine cancer	1.45e-05	0.000379	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.45e-05	0.000379	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.44e-05	0.000377	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—POLD1—uterine cancer	1.44e-05	0.000377	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.44e-05	0.000376	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.43e-05	0.000376	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.42e-05	0.000371	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.41e-05	0.00037	CbGpPWpGaD
Clomifene—EBP—Metabolism—EP300—uterine cancer	1.41e-05	0.000369	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—INHBA—uterine cancer	1.4e-05	0.000368	CbGpPWpGaD
Clomifene—Nausea—Doxorubicin—uterine cancer	1.4e-05	9.94e-05	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.39e-05	0.000365	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—EZH2—uterine cancer	1.39e-05	0.000363	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000361	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.37e-05	0.000359	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKR1B1—uterine cancer	1.37e-05	0.000358	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—STAR—uterine cancer	1.37e-05	0.000358	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	1.35e-05	0.000354	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.35e-05	0.000353	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.34e-05	0.000352	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000341	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—ESR2—uterine cancer	1.28e-05	0.000337	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.27e-05	0.000331	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.26e-05	0.000331	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.2e-05	0.000315	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.2e-05	0.000315	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—RRM2—uterine cancer	1.2e-05	0.000314	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.18e-05	0.000308	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.17e-05	0.000307	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.17e-05	0.000306	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—DCN—uterine cancer	1.16e-05	0.000305	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—MTHFR—uterine cancer	1.15e-05	0.000301	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—POLD1—uterine cancer	1.14e-05	0.000298	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.11e-05	0.00029	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.1e-05	0.000289	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.000287	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKR1B1—uterine cancer	1.09e-05	0.000286	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—STAR—uterine cancer	1.09e-05	0.000286	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.08e-05	0.000283	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—POLD1—uterine cancer	1.07e-05	0.000281	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.06e-05	0.000278	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—CDKN2B—uterine cancer	1.05e-05	0.000274	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CA—uterine cancer	1.04e-05	0.000273	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000271	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.03e-05	0.00027	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—STK11—uterine cancer	1.01e-05	0.000265	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-05	0.000265	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKR1C1—uterine cancer	1e-05	0.000262	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.75e-06	0.000255	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKR1C3—uterine cancer	9.74e-06	0.000255	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—SMAD3—uterine cancer	9.55e-06	0.00025	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.51e-06	0.000249	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PGR—uterine cancer	9.49e-06	0.000249	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—RRM2—uterine cancer	9.47e-06	0.000248	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.29e-06	0.000243	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.29e-06	0.000243	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—DCN—uterine cancer	9.2e-06	0.000241	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.07e-06	0.000238	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—YWHAE—uterine cancer	9.05e-06	0.000237	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—RRM2—uterine cancer	8.93e-06	0.000234	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKR1B1—uterine cancer	8.7e-06	0.000228	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—STAR—uterine cancer	8.7e-06	0.000228	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FBXW7—uterine cancer	8.68e-06	0.000227	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—DCN—uterine cancer	8.67e-06	0.000227	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP11A1—uterine cancer	8.66e-06	0.000227	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.6e-06	0.000225	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—POLD1—uterine cancer	8.56e-06	0.000224	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—uterine cancer	8.52e-06	0.000223	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.28e-06	0.000217	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKR1C3—uterine cancer	8.18e-06	0.000214	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP11A1—uterine cancer	8.17e-06	0.000214	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—STK11—uterine cancer	8.07e-06	0.000211	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP19A1—uterine cancer	8.07e-06	0.000211	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKR1C1—uterine cancer	8e-06	0.00021	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKR1C3—uterine cancer	7.71e-06	0.000202	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—MTHFR—uterine cancer	7.61e-06	0.000199	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.61e-06	0.000199	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STK11—uterine cancer	7.59e-06	0.000199	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.36e-06	0.000193	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—RRM2—uterine cancer	7.13e-06	0.000187	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SOCS3—uterine cancer	7.1e-06	0.000186	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—DCN—uterine cancer	6.92e-06	0.000181	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—POLD1—uterine cancer	6.83e-06	0.000179	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN2B—uterine cancer	6.8e-06	0.000178	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.72e-06	0.000176	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—STAR—uterine cancer	6.72e-06	0.000176	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.71e-06	0.000176	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF1R—uterine cancer	6.6e-06	0.000173	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP11A1—uterine cancer	6.52e-06	0.000171	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTEN—uterine cancer	6.39e-06	0.000167	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKR1C1—uterine cancer	6.39e-06	0.000167	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP19A1—uterine cancer	6.37e-06	0.000167	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—STK11—uterine cancer	6.37e-06	0.000167	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.22e-06	0.000163	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SMAD3—uterine cancer	6.21e-06	0.000163	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKR1C3—uterine cancer	6.16e-06	0.000161	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—EP300—uterine cancer	6.1e-06	0.00016	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—MTHFR—uterine cancer	6.06e-06	0.000159	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—STK11—uterine cancer	6.01e-06	0.000157	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP19A1—uterine cancer	6.01e-06	0.000157	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FGFR2—uterine cancer	5.92e-06	0.000155	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—RRM2—uterine cancer	5.69e-06	0.000149	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.64e-06	0.000148	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—DCN—uterine cancer	5.53e-06	0.000145	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.38e-06	0.000141	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—POLD1—uterine cancer	5.27e-06	0.000138	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP11A1—uterine cancer	5.21e-06	0.000136	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.93e-06	0.000129	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.92e-06	0.000129	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP19A1—uterine cancer	4.8e-06	0.000126	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—STK11—uterine cancer	4.8e-06	0.000126	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—MTHFR—uterine cancer	4.79e-06	0.000125	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—MTHFR—uterine cancer	4.52e-06	0.000118	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—uterine cancer	4.51e-06	0.000118	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCL2—uterine cancer	4.46e-06	0.000117	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—RRM2—uterine cancer	4.39e-06	0.000115	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—DCN—uterine cancer	4.27e-06	0.000112	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTEN—uterine cancer	4.24e-06	0.000111	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—EP300—uterine cancer	4.04e-06	0.000106	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.02e-06	0.000105	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.98e-06	0.000104	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—STK11—uterine cancer	3.83e-06	0.0001	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.83e-06	0.0001	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.8e-06	9.94e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB2—uterine cancer	3.72e-06	9.74e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—uterine cancer	3.69e-06	9.65e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—MTHFR—uterine cancer	3.61e-06	9.45e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.6e-06	9.42e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL8—uterine cancer	3.53e-06	9.24e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1B—uterine cancer	3.44e-06	9.02e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.43e-06	8.98e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTEN—uterine cancer	3.37e-06	8.83e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.25e-06	8.52e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—EP300—uterine cancer	3.22e-06	8.42e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTEN—uterine cancer	3.17e-06	8.31e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EP300—uterine cancer	3.02e-06	7.92e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.99e-06	7.83e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—STK11—uterine cancer	2.96e-06	7.75e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.96e-06	7.75e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—MTHFR—uterine cancer	2.88e-06	7.54e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—uterine cancer	2.86e-06	7.5e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—uterine cancer	2.83e-06	7.41e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—uterine cancer	2.81e-06	7.36e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTEN—uterine cancer	2.66e-06	6.98e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—EP300—uterine cancer	2.54e-06	6.66e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.54e-06	6.65e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTEN—uterine cancer	2.51e-06	6.58e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—uterine cancer	2.44e-06	6.39e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—uterine cancer	2.43e-06	6.38e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—EP300—uterine cancer	2.4e-06	6.27e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—uterine cancer	2.38e-06	6.23e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.24e-06	5.86e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—MTHFR—uterine cancer	2.22e-06	5.82e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—uterine cancer	2.16e-06	5.67e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—uterine cancer	2.07e-06	5.42e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTEN—uterine cancer	2.01e-06	5.26e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—uterine cancer	1.94e-06	5.09e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—EP300—uterine cancer	1.91e-06	5.01e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.88e-06	4.92e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—uterine cancer	1.83e-06	4.79e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.77e-06	4.64e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTEN—uterine cancer	1.6e-06	4.2e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—uterine cancer	1.54e-06	4.02e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—EP300—uterine cancer	1.53e-06	4e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—uterine cancer	1.45e-06	3.79e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—uterine cancer	1.42e-06	3.71e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTEN—uterine cancer	1.24e-06	3.24e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—EP300—uterine cancer	1.18e-06	3.09e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—uterine cancer	1.16e-06	3.03e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.13e-06	2.96e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—uterine cancer	9.23e-07	2.42e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.72e-07	2.28e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—uterine cancer	7.12e-07	1.87e-05	CbGpPWpGaD
